DK1071418T3 - Nye behandlinger til nervelidelser - Google Patents

Nye behandlinger til nervelidelser

Info

Publication number
DK1071418T3
DK1071418T3 DK99918423T DK99918423T DK1071418T3 DK 1071418 T3 DK1071418 T3 DK 1071418T3 DK 99918423 T DK99918423 T DK 99918423T DK 99918423 T DK99918423 T DK 99918423T DK 1071418 T3 DK1071418 T3 DK 1071418T3
Authority
DK
Denmark
Prior art keywords
new treatments
nerve disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
DK99918423T
Other languages
Danish (da)
English (en)
Inventor
John Michael Mccall
Duncan Paul Taylor
Voigtlander Philip F Von
Erik Ho Fong Wong
Adriana Dubini
Original Assignee
Pharmacia Italia Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa, Upjohn Co filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK1071418T3 publication Critical patent/DK1071418T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
DK99918423T 1998-04-13 1999-04-02 Nye behandlinger til nervelidelser DK1071418T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
EP99918423A EP1071418B1 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (1)

Publication Number Publication Date
DK1071418T3 true DK1071418T3 (da) 2005-01-03

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918423T DK1071418T3 (da) 1998-04-13 1999-04-02 Nye behandlinger til nervelidelser

Country Status (25)

Country Link
US (1) US6391876B1 (pl)
EP (1) EP1071418B1 (pl)
JP (1) JP2002511408A (pl)
KR (1) KR100555279B1 (pl)
CN (1) CN1197569C (pl)
AT (1) ATE277617T1 (pl)
AU (1) AU755612B2 (pl)
BR (1) BR9909476A (pl)
CA (1) CA2320722A1 (pl)
DE (1) DE69920679T2 (pl)
DK (1) DK1071418T3 (pl)
EA (1) EA003546B1 (pl)
ES (1) ES2228035T3 (pl)
HU (1) HUP0101748A3 (pl)
IL (1) IL138887A0 (pl)
IT (1) IT1305322B1 (pl)
NO (1) NO20005131L (pl)
NZ (1) NZ507693A (pl)
PL (1) PL194039B1 (pl)
PT (1) PT1071418E (pl)
SI (1) SI1071418T1 (pl)
SK (1) SK14482000A3 (pl)
TR (1) TR200002970T2 (pl)
WO (1) WO1999052518A2 (pl)
ZA (1) ZA200004480B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
CN1660109A (zh) 1999-07-01 2005-08-31 法玛西雅厄普约翰美国公司 高度选择性去甲肾上腺素再摄取抑制剂及其用途
DK1493442T3 (da) * 1999-07-01 2005-12-19 Pharmacia & Upjohn Co Llc Reboxetin til behandling af perifer neuropati
AU2002217757A1 (en) * 2000-11-15 2002-05-27 Eli Lilly And Company Treatment of anxiety disorders
AU2003227755B2 (en) * 2002-06-17 2009-01-15 Pfizer Italia S.R.L. Pharmaceutical salts of reboxetine
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
AU9692898A (en) 1997-10-17 1999-05-10 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
PL194039B1 (pl) 2007-04-30
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
EP1071418A2 (en) 2001-01-31
CA2320722A1 (en) 1999-10-21
SK14482000A3 (sk) 2001-08-06
DE69920679T2 (de) 2006-03-02
AU755612B2 (en) 2002-12-19
IL138887A0 (en) 2001-11-25
TR200002970T2 (tr) 2001-01-22
CN1293569A (zh) 2001-05-02
NO20005131D0 (no) 2000-10-12
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24
EA200001058A1 (ru) 2001-04-23
NO20005131L (no) 2000-10-12
CN1197569C (zh) 2005-04-20
NZ507693A (en) 2003-08-29
ATE277617T1 (de) 2004-10-15
ES2228035T3 (es) 2005-04-01
SI1071418T1 (en) 2005-04-30
EA003546B1 (ru) 2003-06-26
HUP0101748A3 (en) 2001-12-28
KR100555279B1 (ko) 2006-03-03
US6391876B1 (en) 2002-05-21
PL346294A1 (en) 2002-01-28
WO1999052518A2 (en) 1999-10-21
AU3635199A (en) 1999-11-01
PT1071418E (pt) 2004-12-31
WO1999052518A3 (en) 1999-12-02
DE69920679D1 (de) 2004-11-04
EP1071418B1 (en) 2004-09-29
BR9909476A (pt) 2000-12-19
JP2002511408A (ja) 2002-04-16
ITMI980870A1 (it) 1999-10-23

Similar Documents

Publication Publication Date Title
UA43385C2 (uk) Спосіб лікування синдрому дефіциту уваги/гіперактивності
DK1071418T3 (da) Nye behandlinger til nervelidelser
DE602004015257D1 (de) Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
MY134110A (en) Combinations of reboxetine and neuroleptic agents
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
HK1115329A1 (en) Use of (1s, 2r) enantiomer of milnacipran for the preparation of a medicine
DE50313386D1 (de) Mittelwalze eines Kalanders mit einer Tilgeranordnung
NO20021035L (no) Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
AR021155A1 (es) Tratamiento de desordenes neuroticos
MY136367A (en) Treatment of cognitive failure
AU2561095A (en) Method and apparatus for destruction of undesired vegetation using ultra-violet light
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
WO2002040006A3 (en) Treatment of anxiety disorders
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
DK1332229T3 (da) Fremgangsmåde til screening af midler til at behandle overvægt
ATE486880T1 (de) Neue stromelysin inhibitoren
FI972378A0 (fi) Menetelmä orgaanisia ja epäorgaanisia yhdisteitä sisältävien jätevesien katalyyttiseksi käsittelemiseksi
DE50115630D1 (de) Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen